"The efficiency and collaboration of the RQM+ team in conducting our IVD clinical study was exceptional. The collaboration across US and EU geographies was seamless. We have found our go to CRO partner for future IVD projects."
- Laboratory Manager, Multinational IVD Manufacturer
With a team that includes technical and regulatory expertise, you can be confident your study will be planned and executed efficiently, and meet the high standards required for final clearance and approval through complex regulatory pathways (including 510(k), De Novo, PMA, and IVDR).
At RQM+, we believe there is no one-size fits all approach for IVD clinical trials. Each project is designed and executed to support our clients. We take a collaborative operational approach that is tailored to the intended use of the device, the envisioned markets, and the client's needs.
Our technical expertise and deep clinical trials backgrounds can support IVDs from any therapeutic area.
RQM+ will consider the specific requirements and claims of the device when supporting study design. Study design considerations for certain IVDs:
Margot Borgel, Ph.D. is the Director for IVD Intelligence and Innovation at RQM+ where she provides her expertise in IVDR implementation and notified body requirements. Prior to RQM+, Margot was a Technical Specialist at BSI, where she performed technical reviews for IVDR, IVDD and UKCA certification. She is especially passionate about certification of high-risk devices and enjoyed seeing these devices through IVDR certification while at BSI. Before her notified body work, Margot worked for Immucor, Inc. where she held roles in R&D, manufacturing technical support and manufacturing.
“The RQM+ IVD Team has the tools and expertise to provide IVD organizations a clear path to successful IVDR certification.”
Cari Kniola is a clinical research professional with a strong foundation in project management and clinical trials. Her career journey, beginning with roles as a Clinical Research Associate (CRA) and Clinical Trial Manager (CTM), has led her to RQM+, where she plays a pivotal role in supporting IVD manufacturers. With her expertise centered on the strategic and operational aspects of clinical trials, Cari offers a focused and impactful approach to IVD clinical research, ensuring that projects are managed effectively and comply with the highest standards.
"At RQM+, my focus is on navigating the intricate landscape of IVD clinical research through effective project management and clinical trial expertise. Our aim is to elevate the standard of diagnostics, ensuring they are not just compliant but also significantly enhance patient care."
GLOBAL BOTTOM CTA INSTRUCTIONS:
To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.
Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!
United States HQ 2790 Mosside Blvd. United States (U.S.) |
Europe HQ 3rd Floor, 1 Ashley Road Altrincham, Cheshire, |
©2024 RQM+ All Rights Reserved | Privacy Policy | Terms of Use